华润医药(03320.HK):昆药集团预计中期归母净亏损为3.3亿元至4亿元 同比盈转亏

智通财经
Jul 14
【华润医药(03320.HK):昆药集团预计中期归母净亏损为3.3亿元至4亿元 同比盈转亏】智通财经APP讯,华润医药(03320.HK)发布公告,根据昆药集团财务部门的初步估算,(i)截至2026年6月30日止六个月(本报告期)上市公司股东应占净亏损预计将介乎人民币3.3亿元至人民币4亿元,较上年同期减少302%至266%,且将出现亏损;以及本报告期上市公司股东应占净亏损(扣除非经常收益或亏损后)预计将介乎人民币3.5亿元至人民币4.3亿元,较上年同期减少385%至332%。上述资料乃基于昆药集团财务部门之初步计算,且未经审核。应以昆药集团即将发布的2026年中期报告所载财务资料为准。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10